Gene · 8288
Papers2,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Colloidal Behavior and Biodegradation of Engineered Carbon-Based Nanomaterials in Aquatic Environment. | Nanomaterials (Basel) | 2022 | 36500771 | PubTator, text mining | PubMed |
IL-5 Serum and Appendicular Lavage Fluid Concentrations Correlate with Eosinophilic Infiltration in the Appendicular Wall Supporting a Role for a Hypersensitivity Type I Reaction in Acute Appendicitis. | Int J Mol Sci | 2022 | 36499410 | PubTator, text mining | PubMed |
| Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients. | Front Immunol | 2022 | 36466856 | PubTator, text mining | PubMed |
| "Liquid biopsy" - extracellular vesicles as potential novel players towards precision medicine in asthma. | Front Immunol | 2022 | 36466836 | PubTator, text mining | PubMed |
| Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19. | J Immunol Res | 2022 | 36465717 | PubTator, text mining | PubMed |
| Immunologic and pathologic characterization of a novel swine biomedical research model for eosinophilic esophagitis. | Front Allergy | 2022 | 36452260 | PubTator, text mining | PubMed |
| Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers. | Biomater Res | 2022 | 36435846 | PubTator, text mining | PubMed |
| Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma. | Cancers (Basel) | 2022 | 36428768 | PubTator, text mining | PubMed |
| Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy. | Antioxidants (Basel) | 2022 | 36421487 | PubTator, text mining | PubMed |
| Overview of the Mechanisms of Oxidative Stress: Impact in Inflammation of the Airway Diseases. | Antioxidants (Basel) | 2022 | 36421423 | PubTator, text mining | PubMed |
| The social capital effect on HIV/AIDS preventive efforts: a meta-analysis. | J Med Life | 2022 | 36420290 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Eosinophils in filarial infections: Inducers of protection or pathology? | Front Immunol | 2022 | 36389745 | PubTator, text mining | PubMed |
| Immunopathologic Role of Eosinophils in Eosinophilic Chronic Rhinosinusitis. | Int J Mol Sci | 2022 | 36362100 | PubTator, text mining | PubMed |
| Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience. | Biomedicines | 2022 | 36359208 | PubTator, text mining | PubMed |
| Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report. | Medicine (Baltimore) | 2022 | 36343053 | PubTator, text mining | PubMed |
| Plant polysaccharides with anti-lung injury effects as a potential therapeutic strategy for COVID-19. | Front Pharmacol | 2022 | 36339607 | PubTator, text mining | PubMed |
| ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways. | Oxid Med Cell Longev | 2022 | 36312897 | PubTator, text mining | PubMed |
| The Changes in Bacterial Microbiome Associated with Immune Disorder in Allergic Respiratory Disease. | Microorganisms | 2022 | 36296340 | PubTator, text mining | PubMed |
| Galectin-10 as a Potential Biomarker for Eosinophilic Diseases. | Biomolecules | 2022 | 36291593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8288/papers?page=16